You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This case report details a rare fatality from moclobemide, a selective reversible MAO-A inhibitor. The death was attributed to moclobemide toxicity alone, not serotonin syndrome, highlighting potential risks.
Area of Science:
Background:
Observation:
Findings:
Implications: